Differential effects of pioglitazone on advanced atherosclerotic lesions.
Thorp
Edward
E
Tabas
Ira
I
D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D009336:Necrosis; D047495:PPAR gamma / Q000819:agonists; D000077205:Pioglitazone; D011973:Receptors, LDL / Q000172:deficiency; D045162:Thiazolidinediones / Q000494:pharmacology* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D047495:PPAR gamma; D011973:Receptors, LDL; D045162:Thiazolidinediones; D000077205:Pioglitazone